Management of ischemic optic neuropathies

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Expert Review of Ophthalmology

• Publication date

  2017-02-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/17469899.2017.1291341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A Single Intravitreal Injection of Ranibizumab Provides No Neuroprotection in a Nonhuman Primate Model of Moderate-to-Severe Nonarteritic Anterior Ischemic Optic Neuropathy.

  2015cited by this paper
• Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses

  2015cited by this paper
• Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.

  2014cited by this paper
• Toxicological and Pharmacokinetic Properties of QPI-1007, a Chemically Modified Synthetic siRNA Targeting Caspase 2 mRNA, Following Intravitreal Injection

  2014cited by this paper
• Perioperative visual loss after spine surgery.

  2014cited by this paper
• Ciliary neurotrophic factor (CNTF)-mediated ganglion cell survival in a rodent model of non-arteritic anterior ischaemic optic neuropathy (NAION)

  2014cited by this paper
• Positioning patients for spine surgery: Avoiding uncommon position-related complications.

  2014cited by this paper
• Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy – retrospective analysis

  2014cited by this paper
• Systemic corticosteroids in nonarteritic ischemic optic neuropathy

  2014cited by this paper
• Intravitreal triamcinolone injections in non-arteritic anterior ischemic optic neuropathy

  2014cited by this paper
• Recovery of Visual Function after Administration of Dabigatran Etexilate

  2014cited by this paper
• Systemic vascular safety of ranibizumab for age-related macular degeneration: systematic review and meta-analysis of randomized trials.

  2014cited by this paper
• Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis

  2014cited by this paper
• Ocular vascular occlusive disorders: natural history of visual outcome.

  2014cited by this paper
• Sustained neuroprotection from a single intravitreal injection of PGJ₂ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy.

  2014cited by this paper
• Treatment of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids

  2013cited by this paper
• Efficacy of Intravitreal Ranibizumab Injection in Acute Nonarteritic Ischemic Optic Neuropathy: A Long-Term Follow Up§

  2013cited by this paper
• MYOCARDIAL INFARCTION AFTER INTRAVITREAL VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS: A Whole Population Study

  2013cited by this paper
• Ischemic optic neuropathies — where are we now?

  2013cited by this paper
• Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy.

  2013cited by this paper
• Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial

  2013cited by this paper
• Pallid disc edema and choroidal perfusion delay in posthemodialysis nonarteritic ischemic optic neuropathy.

  2013cited by this paper
• Effects of Crystalloid versus Colloid and the &agr;-2 Agonist Brimonidine versus Placebo on Intraocular Pressure during Prone Spine Surgery: A Factorial Randomized Trial

  2012cited by this paper
• Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study

  2012cited by this paper
• PGJ2 Provides Prolonged CNS Stroke Protection by Reducing White Matter Edema

  2012cited by this paper
• Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids?

  2012cited by this paper
• Insight into 144 patients with ocular vascular events during VEGF antagonist injections

  2012cited by this paper
• A novel rodent model of posterior ischemic optic neuropathy.

  2012cited by this paper
• Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis.

  2012cited by this paper
• Risk Factors Associated with Ischemic Optic Neuropathy after Spinal Fusion Surgery

  2012cited by this paper
• Tocilizumab: a novel therapy for patients with large-vessel vasculitis.

  2012cited by this paper
• Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients.

  2011cited by this paper
• Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy.

  2011influential reference
• Management of ischemic optic neuropathies

  2011cited by this paper
• Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy?

  2010cited by this paper
• Intravitreal Ranibizumab Injection for Nonarteritic Ischemic Optic Neuropathy

  2010cited by this paper
• Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy?

  2010cited by this paper
• Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration.

  2010cited by this paper
• Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy

  2010cited by this paper
• Role of steroid therapy in nonarteritic anterior ischemic optic neuropathy.

  2010cited by this paper
• Pathogenesis of nonarteritic anterior ischemic optic neuropathy.

  2009cited by this paper
• The Effect of an Intravitreal Triamcinolone Acetonide Injection for Acute Nonarteritic Anterior Ischemic Optic Neuropathy

  2009cited by this paper
• Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy

  2008cited by this paper
• A primate model of nonarteritic anterior ischemic optic neuropathy.

  2008cited by this paper
• Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis.

  2008cited by this paper
• Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients.

  2008cited by this paper
• Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome.

  2008cited by this paper
• Intravitreal triamcinolone acetonide injection for acute non‐arteritic anterior ischaemic optic neuropathy *

  2008cited by this paper
• Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.

  2007cited by this paper
• Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy

  2007cited by this paper
• A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects

  2007cited by this paper
• Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection.

  2007cited by this paper
• Anterior ischemic optic neuropathy in patients younger than 50 years.

  2007cited by this paper
• Intravitreal Triamcinolone Improves Recovery of Visual Acuity in Nonarteritic Anterior Ischemic Optic Neuropathy

  2007cited by this paper
• Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

  2007cited by this paper
• Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.

  2006cited by this paper
• No additional steroid‐sparing effect of cyclosporine A in giant cell arteritis

  2006cited by this paper
• Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat.

  2006cited by this paper
• Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial

  2006cited by this paper
• Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.

  2005cited by this paper
• Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia.

  2005cited by this paper
• High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery.

  2005cited by this paper
• The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.

  2004cited by this paper
• The 15-Deoxy-δ12,14-Prostaglandin J2 Inhibits the Inflammatory Response in Primary Rat Astrocytes via Down-Regulating Multiple Steps in Phosphatidylinositol 3-Kinase-Akt-NF-κB-p300 Pathway Independent of Peroxisome Proliferator-Activated Receptor γ1

  2004cited by this paper
• CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway

  2004cited by this paper
• Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management

  2004cited by this paper
• Role of alpha-2 agonists in neuroprotection.

  2003cited by this paper
• Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor α (CNTFRα)

  2003cited by this paper
• Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor alpha (CNTFRalpha).

  2003cited by this paper
• Recovery of visual function in patients with biopsy-proven giant cell arteritis.

  2003cited by this paper
• Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy.

  2003cited by this paper
• Recovery of Visual Function in Patients with Biopsy-Proven Giant Cell Arteritis

  2003cited by this paper
• The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study.

  2002cited by this paper
• Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.

  2001cited by this paper
• Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.

  2001cited by this paper
• The blood supply of the optic nerve head and the evaluation of it - myth and reality.

  2001cited by this paper
• Clinical spectrum of posterior ischemic optic neuropathy.

  2001cited by this paper
• Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update.

  2000cited by this paper
• Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy.

  2000cited by this paper
• From the Lab to the Clinic: Activation of an Alpha-2 agonist Pathway is Neuroprotective in Models of Retinal and Optic Nerve Injury

  1999cited by this paper
• Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy

  1999cited by this paper
• Expression of CNTF in Müller cells of the rat retina after pressure-induced ischemia.

  1999cited by this paper
• Occult giant cell arteritis: ocular manifestations.

  1998cited by this paper
• Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment.

  1998cited by this paper
• Corticosteroids in the treatment of rheumatologic diseases

  1997cited by this paper
• Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina.

  1997cited by this paper
• Giant cell arteritis: validity and reliability of various diagnostic criteria.

  1997cited by this paper
• Aspirin Reduces the Incidence of Second Eye NAION: A Retrospective Study

  1997cited by this paper
• Evidence for Multiple, Local Functions of Ciliary Neurotrophic Factor (CNTF) in Retinal Development: Expression of CNTF and Its Receptor and In Vitro Effects on Target Cells

  1997cited by this paper
• Incidence of nonarteritic anterior ischemic optic neuropathy.

  1997cited by this paper
• Incidence of Nonarteritic Anteripr Ischemic Optic Neuropathy

  1997cited by this paper
• Aspirin therapy in nonarteritic anterior ischemic optic neuropathy.

  1997cited by this paper
• Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.

  1996cited by this paper
• The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy.

  1996cited by this paper
• Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy.

  1996cited by this paper
• Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group.

  1995influential reference
• THE OPTIC NERVE HEAD CIRCULATION IN HEALTH AND DISEASE

  1995cited by this paper
• Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy.

  1994cited by this paper
• Treatment of giant cell arteritis.

  1994cited by this paper
• Incidence of Nonarteritic and Arteritic Anterior Ischemic Optic Neuropathy: Population‐Based Study in the State of Missouri and Los Angeles County, California

  1994cited by this paper

• Bilateral anterior ischemic optic neuropathy and choroidal ischemia in a patient with COVID‐19 infection

  2023cites this paper
• Oxidative stress in the eye and its role in the pathophysiology of ocular diseases

  2023cites this paper
• Clinical and Mechanistic Review of Amiodarone-Associated Optic Neuropathy

  2022cites this paper
• Construction and functional enrichment analysis of the competitive endogenous RNA regulatory network for nonarteritic anterior ischemic optic neuropathy based on high-throughput sequencing

  2022cites this paper
• A case report of non-arteritic anterior ischaemic optic neuropathy

  2021cites this paper
• Risk Factors for Non-arteritic Anterior Ischemic Optic Neuropathy: A Large Scale Meta-Analysis

  2021cites this paper
• Diabetic Papillopathy on Peripapillary Staphyloma in a 50-year-old Korean Patient

  2018cites this paper